Dermcos Skin Care Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.20 M
- Revenue Growth 8.81%
- Profit Growth -607.96%
- Ebitda -116.68%
- Net Worth -21.55%
- Total Assets -2.19%
About Dermcos Skin Care
Dermcos Skin Care Private Limited (DSCPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 March 2015 (Nine years and 11 months 15 days old ). Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹1.20 M.
Ramanjit Singh and Gurkeerat Kaur serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74140HR2015PTC054861
- Company No.
054861
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Dermcos Skin Care?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramanjit Singh  | Director | 11-Mar-2015 | Current |
| Gurkeerat Kaur | Director | 11-Mar-2015 | Current |
Financial Performance of Dermcos Skin Care.
Dermcos Skin Care Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.81% increase. The company also saw a substantial fall in profitability, with a 607.96% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dermcos Skin Care?
Unlock access to Dermcos Skin Care's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.20 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2022 | Hdfc Bank Limited | ₹1.20 M | Open |
How Many Employees Work at Dermcos Skin Care?
Unlock and access historical data on people associated with Dermcos Skin Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dermcos Skin Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dermcos Skin Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.